206 related articles for article (PubMed ID: 22348113)
1. Computational analysis of mRNA expression profiles identifies microRNA-29a/c as predictor of colorectal cancer early recurrence.
Kuo TY; Hsi E; Yang IP; Tsai PC; Wang JY; Juo SH
PLoS One; 2012; 7(2):e31587. PubMed ID: 22348113
[TBL] [Abstract][Full Text] [Related]
2. Identifying microRNA-mRNA regulatory network in colorectal cancer by a combination of expression profile and bioinformatics analysis.
Fu J; Tang W; Du P; Wang G; Chen W; Li J; Zhu Y; Gao J; Cui L
BMC Syst Biol; 2012 Jun; 6():68. PubMed ID: 22703586
[TBL] [Abstract][Full Text] [Related]
3. Functional role of a long non-coding RNA LIFR-AS1/miR-29a/TNFAIP3 axis in colorectal cancer resistance to pohotodynamic therapy.
Liu K; Yao H; Wen Y; Zhao H; Zhou N; Lei S; Xiong L
Biochim Biophys Acta Mol Basis Dis; 2018 Sep; 1864(9 Pt B):2871-2880. PubMed ID: 29807108
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic performance of microRNA-29a for colorectal cancer: a meta-analysis.
Zhi ML; Liu ZJ; Yi XY; Zhang LJ; Bao YX
Genet Mol Res; 2015 Dec; 14(4):18018-25. PubMed ID: 26782449
[TBL] [Abstract][Full Text] [Related]
5. microRNA expression profile in stage III colorectal cancer: circulating miR-18a and miR-29a as promising biomarkers.
Brunet Vega A; Pericay C; Moya I; Ferrer A; Dotor E; Pisa A; Casalots À; Serra-Aracil X; Oliva JC; Ruiz A; Saigí E
Oncol Rep; 2013 Jul; 30(1):320-6. PubMed ID: 23673725
[TBL] [Abstract][Full Text] [Related]
6. Identifying the key genes and microRNAs in colorectal cancer liver metastasis by bioinformatics analysis and in vitro experiments.
Zhang T; Guo J; Gu J; Wang Z; Wang G; Li H; Wang J
Oncol Rep; 2019 Jan; 41(1):279-291. PubMed ID: 30542696
[TBL] [Abstract][Full Text] [Related]
7. The role of microRNA in metastatic colorectal cancer and its significance in cancer prognosis and treatment.
Tokarz P; Blasiak J
Acta Biochim Pol; 2012; 59(4):467-74. PubMed ID: 23173124
[TBL] [Abstract][Full Text] [Related]
8. MiR-29a-3p: a potential biomarker and therapeutic target in colorectal cancer.
Mo WY; Cao SQ
Clin Transl Oncol; 2023 Mar; 25(3):563-577. PubMed ID: 36355327
[TBL] [Abstract][Full Text] [Related]
9. MiRNA-362-3p induces cell cycle arrest through targeting of E2F1, USF2 and PTPN1 and is associated with recurrence of colorectal cancer.
Christensen LL; Tobiasen H; Holm A; Schepeler T; Ostenfeld MS; Thorsen K; Rasmussen MH; Birkenkamp-Demtroeder K; Sieber OM; Gibbs P; Lubinski J; Lamy P; ; Laurberg S; Oster B; Hansen KQ; Hagemann-Madsen R; Byskov K; Ørntoft TF; Andersen CL
Int J Cancer; 2013 Jul; 133(1):67-78. PubMed ID: 23280316
[TBL] [Abstract][Full Text] [Related]
10. Fecal miR-29a and miR-224 as the noninvasive biomarkers for colorectal cancer.
Zhu Y; Xu A; Li J; Fu J; Wang G; Yang Y; Cui L; Sun J
Cancer Biomark; 2016; 16(2):259-64. PubMed ID: 26756616
[TBL] [Abstract][Full Text] [Related]
11. Circulating microRNA-1290 as a novel diagnostic and prognostic biomarker in human colorectal cancer.
Imaoka H; Toiyama Y; Fujikawa H; Hiro J; Saigusa S; Tanaka K; Inoue Y; Mohri Y; Mori T; Kato T; Toden S; Goel A; Kusunoki M
Ann Oncol; 2016 Oct; 27(10):1879-86. PubMed ID: 27502702
[TBL] [Abstract][Full Text] [Related]
12. Dynamic plasma microRNAs are biomarkers for prognosis and early detection of recurrence in colorectal cancer.
Yuan Z; Baker K; Redman MW; Wang L; Adams SV; Yu M; Dickinson B; Makar K; Ulrich N; Böhm J; Wurscher M; Westerhoff M; Medwell S; Moonka R; Sinanan M; Fichera A; Vickers K; Grady WM
Br J Cancer; 2017 Oct; 117(8):1202-1210. PubMed ID: 28809863
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-mRNA interactions underlying colorectal cancer molecular subtypes.
Cantini L; Isella C; Petti C; Picco G; Chiola S; Ficarra E; Caselle M; Medico E
Nat Commun; 2015 Nov; 6():8878. PubMed ID: 27305450
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA and targeted mRNA expression profiling analysis in human colorectal adenomas and adenocarcinomas.
Gattolliat CH; Uguen A; Pesson M; Trillet K; Simon B; Doucet L; Robaszkiewicz M; Corcos L
Eur J Cancer; 2015 Feb; 51(3):409-20. PubMed ID: 25586944
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic silencing of miR-137 is an early event in colorectal carcinogenesis.
Balaguer F; Link A; Lozano JJ; Cuatrecasas M; Nagasaka T; Boland CR; Goel A
Cancer Res; 2010 Aug; 70(16):6609-18. PubMed ID: 20682795
[TBL] [Abstract][Full Text] [Related]
16. Serum-based microRNA signature predicts relapse and therapeutic outcome of adjuvant chemotherapy in colorectal cancer patients.
Ji D; Qiao M; Yao Y; Li M; Chen H; Dong Q; Jia J; Cui X; Li Z; Xia J; Gu J
EBioMedicine; 2018 Sep; 35():189-197. PubMed ID: 30166271
[TBL] [Abstract][Full Text] [Related]
17. High expression of miR-181c as a predictive marker of recurrence in stage II colorectal cancer.
Yamazaki N; Koga Y; Taniguchi H; Kojima M; Kanemitsu Y; Saito N; Matsumura Y
Oncotarget; 2017 Jan; 8(4):6970-6983. PubMed ID: 28036302
[TBL] [Abstract][Full Text] [Related]
18. Integrative systematic review meta-analysis and bioinformatics identifies MicroRNA-21 and its target genes as biomarkers for colorectal adenocarcinoma.
Saheb Sharif-Askari N; Saheb Sharif-Askari F; Guraya SY; Bendardaf R; Hamoudi R
Int J Surg; 2020 Jan; 73():113-122. PubMed ID: 31756546
[TBL] [Abstract][Full Text] [Related]
19. Identification and prediction of novel non-coding and coding RNA-associated competing endogenous RNA networks in colorectal cancer.
Liang Y; Zhang C; Ma MH; Dai DQ
World J Gastroenterol; 2018 Dec; 24(46):5259-5270. PubMed ID: 30581274
[TBL] [Abstract][Full Text] [Related]
20. Functional Prediction of Candidate MicroRNAs for CRC Management Using in Silico Approach.
Fadaka AO; Pretorius A; Klein A
Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31635135
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
